Abstract:Inflammation and immunity are known to strongly influence aortic fibrosis leading to stiffening and remodelling. We have shown that genetic and pharmacological ablation of B cells affords protection from the development of aortic stiffening and remodelling associated with hypertension. Whether this protective phenotype is due to systemic effects such as reduced antibody secretion, or local B cell effector functions within the aorta remains unclear. Using single-cell transcriptomics, this study aimed to characterise the B cell populations present in the mouse aorta and identify phenotypes/effector functions which may drive inflammation and aortic remodelling. Hypertension was induced in 12-week-old C57BL6/J mice by infusion of angiotensin II (0.7 mg/kg/day; s.c.) for 28-days via osmotic minipumps. Normotensive mice received vehicle infusion (0.5% NaCl, 0.1% acetic acid). Weekly systolic blood pressure (SBP) measurements were acquired by tail-cuff plethysmography. High-resolution ultrasound imaging was used for pulse wave velocity (PWV) measurements on day 28. Thoracic and abdominal aortas were then isolated and digested for single-cell transcriptomic analyses. Aortic suspensions were stained with Calcein Blue and Vybrant Ruby to sort for metabolically active, nucleated cells. RNA libraries were generated using the 10x Chromium platform. Angiotensin II caused significant increases in SBPs (∼180 mmHg) compared to vehicle treated mice (∼120 mmHg). Hypertensive (HT) mice had increased aortic PWV (∼4 m/s) compared to normotensive (NT) mice (∼1 m/s). Single-cell transcriptomic analyses revealed a near 2-fold increase in B cells present in the aorta of hypertensive mice. Leiden-based community detection identified 7 clusters within the aortic B cell population, including pro-B cells, pre-BCR-independent B cells, transitional B cell populations, B1 and B2 B cells, as well as antibody secreting cells. A greater number of B2 B cells was observed in the hypertensive aorta (58% HT vs 36% NT), without an observable increase in B1 B cell numbers. Gene ontology (GO) analysis of aortic B2 B cells from angiotensin II-treated mice revealed an upregulation in biological processes associated with B cell proliferation (GO:0042100), B cell activation (GO:0042113) and leukocyte differentiation (GO:0002521) compared to vehicle controls. Interestingly, the majority of antibody secreting cells in the aorta appear to be derived from B1 B cells in both vehicle (∼82%) and angiotensin II-treated mice (∼96%). In summary, hypertension is associated with a divergent aortic B cell transcriptome reflective of an augmented immune response, with observable shifts in composition which may be associated with inflammation and aortic remodelling.

Abstract 10884: B-Cell-Mediated Sodium and Water Retention Contributes to Heart Failure Pathogenesis

Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis

Abstract 87: the Accumulation of Myeloid-derived Suppressor Cells is a Compensatory Response to the Development of Hypertension

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

B cell-mediated antigen presentation promotes adverse cardiac remodeling in chronic heart failure

Abstract P2004: T Lymphocytes Promote Diastolic Dysfunction And Fibrosis In A Non-Hypertensive Angiotensin II Mouse Model Of Heart Failure

CCL24/CCR3 Axis Plays a Central Role in Angiotensin II–induced Heart Failure by Stimulating M2 Macrophage Polarization and Fibroblast Activation

Abstract 482: Beta-catenin Activation in Cardiac Fibroblasts Modulates the Immune Micro-environment to Promote Fibrosis and Heart Failure Following Chronic Injury

Role of Bone Marrow-Derived CD11c+ Dendritic Cells in Systolic Overload-Induced Left Ventricular Inflammation, Fibrosis and Hypertrophy

Myocardial B cells have specific gene expression and predicted interactions in dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy

Persistent transcriptional changes in cardiac adaptive immune cells following myocardial infarction: New evidence from the re-analysis of publicly available single cell and nuclei RNA-sequencing data sets

Abstract 11310: T Helper 1 Lymphocytes Promote Diastolic Dysfunction and Fibrosis in a Non-Hypertensive Angiotensin II Mouse Model of Heart Failure

CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs

The association between circulating B cell count and clinical outcomes in patients with heart failure

Abstract MP03: Immunophenotyping A Heart Failure With Preserved Ejection Fraction (HFpEF) Mouse Model With Cellular Indexing Of Transcriptomes And Epitopes (CITE)-seq

PS-B06-9: SINGLE-CELL TRANSCRIPTOMIC PROFILING OF AORTIC B CELLS DURING EXPERIMENTAL HYPERTENSION

HMGB1‐Promoted Neutrophil Extracellular Traps Contribute to Cardiac Diastolic Dysfunction in Mice

Ablation of cardiomyocyte-derived BDNF during development causes myocardial degeneration and heart failure in the adult mouse heart

Depletion of follicular B cell-derived antibody secreting cells does not attenuate angiotensin II-induced hypertension or vascular compliance

Heart Failure Impairs Bone Marrow Hematopoietic Stem Cell Function and Responses to Injury

Impact of blood factors on endothelial cell metabolism and function in two diverse heart failure models